Immuneering CorporationIMRXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P4
Near historical low
vs 5Y Ago
-0.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -13.82% |
| Q3 2025 | 3.38% |
| Q2 2025 | -8.87% |
| Q1 2025 | -22.47% |
| Q4 2024 | 31.49% |
| Q3 2024 | 5.64% |
| Q2 2024 | -4.91% |
| Q1 2024 | -5.47% |
| Q4 2023 | 17.92% |
| Q3 2023 | 6.95% |
| Q2 2023 | -7.97% |
| Q1 2023 | 3.44% |
| Q4 2022 | 5.42% |
| Q3 2022 | 17.90% |
| Q2 2022 | -12.33% |
| Q1 2022 | 13.94% |
| Q4 2021 | 28.08% |
| Q3 2021 | -11.22% |
| Q2 2021 | 29.70% |
| Q1 2021 | 10.23% |
| Q4 2020 | 20.19% |
| Q3 2020 | 26.33% |
| Q2 2020 | 14.09% |
| Q1 2020 | 0.00% |